Perrigo
PRGO
#4808
Rank
$1.84 B
Marketcap
$13.44
Share price
-0.37%
Change (1 day)
-50.50%
Change (1 year)

Revenue for Perrigo (PRGO)

Revenue in 2025 (TTM): $4.28 Billion USD

According to Perrigo's latest financial reports the company's current revenue (TTM ) is $4.28 Billion USD. In 2024 the company made a revenue of $4.37 Billion USD a decrease over the revenue in the year 2023 that were of $4.65 Billion USD. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Perrigo from 1996 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) $4.28 B-2.09%
2024 $4.37 B-6.06%
2023 $4.65 B4.58%
2022 $4.45 B7.56%
2021 $4.13 B-4.3%
2020 $4.32 B-10.6%
2019 $4.83 B2.23%
2018 $4.73 B-4.34%
2017 $4.94 B-1.99%
2016 $5.04 B-5.67%
2015 $5.35 B28.25%
2014 $4.17 B9.8%
2013 $3.79 B16.45%
2012 $3.26 B10.24%
2011 $2.95 B17.64%
2010 $2.51 B18.4%
2009 $2.12 B6.42%
2008 $1.99 B28.42%
2007 $1.55 B11.2%
2006 $1.39 B14.23%
2005 $1.22 B32.65%
2004 $0.92 B9.27%
2003 $0.84 B2.83%
2002 $0.82 B0.89%
2001 $0.81 B13.4%
2000 $0.71 B-15.77%
1999 $0.85 B-2.77%
1998 $0.87 B0.14%
1997 $0.87 B8.62%
1996 $0.80 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
United Therapeutics
UTHR
$3.12 B-26.94%๐Ÿ‡บ๐Ÿ‡ธ USA
Intercept Pharmaceuticals
ICPT
$0.31 B-92.58%๐Ÿ‡บ๐Ÿ‡ธ USA
Catalent
CTLT
$4.42 B 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Endo International
ENDPQ
$2.01 B-53.02%๐Ÿ‡ฎ๐Ÿ‡ช Ireland